<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" 
	xmlns:atom="https://www.w3.org/2005/Atom"
	xmlns:content="https://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="https://wellformedweb.org/CommentAPI/"
	xmlns:dc="https://purl.org/dc/elements/1.1/"
	xmlns:georss="https://www.georss.org/georss"
	xmlns:media="https://search.yahoo.com/mrss/"
	xmlns:mediatize="https://www.mediatize.info/faq-es.php"
 >
<channel>
	<title>Mediatize: assaig</title>
	<atom:link href="https://beta.mediatize.info/rss?p=tags&amp;q=+assaig" rel="self" type="application/rss+xml" />
	<link>https://beta.mediatize.info</link>
	<image><title>Mediatize: assaig</title><link>https://beta.mediatize.info</link><url>https://beta.mediatize.info/img/favicons/logo_64x64.png</url></image>
	<description>Sitio colaborativo de publicación y comunicación entre blogs</description>
	<pubDate>Wed, 26 Oct 2022 21:25:20 +0000</pubDate>
	<generator>https://blog.mediatize.info/</generator>
	<language>es</language>
	<item>
		<mediatize:link_id>55354</mediatize:link_id>
		<mediatize:sub>EsCiencia</mediatize:sub>
		<mediatize:status>published</mediatize:status>
		<mediatize:user>fermin</mediatize:user>
		<mediatize:clicks>27</mediatize:clicks>
		<mediatize:votes>11</mediatize:votes>
		<mediatize:negatives>0</mediatize:negatives>
		<mediatize:karma>152</mediatize:karma>
		<mediatize:comments>3</mediatize:comments>
		<mediatize:url>https://www.naciodigital.cat/noticia/241321/pas-clau-contra-cancer-exit-primer-assaig-farmac-vall-hebron</mediatize:url>
		<title>Paso clave contra el cáncer: éxito en el primer ensayo del fármaco de Vall d'Hebron</title>
		<link>https://beta.mediatize.info/story/paso-clave-contra-cancer-exito-primer-ensayo-farmaco-vall-d</link>
		<comments>https://beta.mediatize.info/story/paso-clave-contra-cancer-exito-primer-ensayo-farmaco-vall-d</comments>
		<pubDate>Wed, 26 Oct 2022 21:25:20 +0000</pubDate>
		<dc:creator>fermin</dc:creator>
		<category><![CDATA[EsCiencia]]></category>
		<category><![CDATA[càncer]]></category>
		<category><![CDATA[assaig]]></category>
		<category><![CDATA[vall dhebron]]></category>
		<guid>https://beta.mediatize.info/story/paso-clave-contra-cancer-exito-primer-ensayo-farmaco-vall-d</guid>
		<description><![CDATA[<img src='https://beta.mediatize.info/cache/00/d8/media_thumb-link-55354.jpeg?1666801180' width='312' height='170' alt='' class='thumbnail' style='float:right;margin-left: 3px' align='right' hspace='3'/><p>En ocho de doce pacientes la enfermedad se estabilizó y se había parado el crecimiento del tumor con 9 semanas de tratamiento.</p><p><strong>etiquetas</strong>: càncer, assaig, vall dhebron</p><p>&#187;&nbsp;<a href="https://beta.mediatize.info/go?id=55354" >noticia original</a> (www.naciodigital.cat)</p>]]></description>
		<media:thumbnail url="https://beta.mediatize.info/cache/00/d8/media_thumb-link-55354.jpeg?1666801180" width='312' height='170' />
		<wfw:commentRss>https://beta.mediatize.info/comments_rss?id=55354</wfw:commentRss>	</item>

</channel>
</rss>
